Expanding the Spectrum of EWSR1::CREM Fusion Tumors: An Unusual Pediatric Intranasal Myxoid Tumor

Pediatr Dev Pathol. 2024 Jan-Feb;27(1):90-95. doi: 10.1177/10935266231199931. Epub 2023 Oct 11.

Abstract

EWSR1::CREM gene fusions are increasingly being recognized in a diverse number of soft tissue tumors, including well-defined entities such as angiomatoid fibrous histiocytoma or clear cell sarcoma, and other unclassifiable tumors. As a group, EWSR1::CREM fused tumors often demonstrate primitive spindle or epithelioid cells, myxoid stroma, and a broad immunophenotype. Herein we present an unusual case of a child diagnosed with an intranasal malignant myxoid tumor harboring an EWSR1::CREM gene fusion. To the best of our knowledge, this is the first case of intranasal myxoid tumor with this particular fusion. Diagnosis and management of the case is discussed.

Keywords: CREM; EWSR1; EWSR1::CREM; intranasal myxoid tumor; pediatric otolaryngology; pediatric tumor.

Publication types

  • Case Reports

MeSH terms

  • Biomarkers, Tumor / genetics
  • Child
  • Cyclic AMP Response Element Modulator / genetics
  • Gene Fusion
  • Histiocytoma, Malignant Fibrous* / genetics
  • Humans
  • Oncogene Proteins, Fusion / genetics
  • RNA-Binding Protein EWS / genetics
  • Sarcoma, Clear Cell*
  • Soft Tissue Neoplasms* / diagnosis
  • Soft Tissue Neoplasms* / genetics
  • Soft Tissue Neoplasms* / pathology

Substances

  • Oncogene Proteins, Fusion
  • Biomarkers, Tumor
  • CREM protein, human
  • Cyclic AMP Response Element Modulator
  • EWSR1 protein, human
  • RNA-Binding Protein EWS